180 related articles for article (PubMed ID: 22942340)
1. N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS.
Welsh P; Doolin O; Willeit P; Packard C; Macfarlane P; Cobbe S; Gudnason V; Di Angelantonio E; Ford I; Sattar N
Eur Heart J; 2013 Feb; 34(6):443-50. PubMed ID: 22942340
[TBL] [Abstract][Full Text] [Related]
2. N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease.
Wannamethee SG; Welsh P; Lowe GD; Gudnason V; Di Angelantonio E; Lennon L; Rumley A; Whincup PH; Sattar N
J Am Coll Cardiol; 2011 Jun; 58(1):56-64. PubMed ID: 21700090
[TBL] [Abstract][Full Text] [Related]
3. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).
Daniels LB; Clopton P; deFilippi CR; Sanchez OA; Bahrami H; Lima JA; Tracy RP; Siscovick D; Bertoni AG; Greenland P; Cushman M; Maisel AS; Criqui MH
Am Heart J; 2015 Dec; 170(6):1170-83. PubMed ID: 26678639
[TBL] [Abstract][Full Text] [Related]
4. NT-proBNP best predictor of cardiovascular events and cardiovascular mortality in secondary prevention in very old age: the Leiden 85-plus Study.
van Peet PG; Drewes YM; de Craen AJ; Gussekloo J; de Ruijter W
PLoS One; 2013; 8(11):e81400. PubMed ID: 24278434
[TBL] [Abstract][Full Text] [Related]
5. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.
Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
Eur Heart J; 2007 Jun; 28(11):1374-81. PubMed ID: 17242007
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification and treatment effect of statins in secondary cardiovascular prevention in old age: Additive value of N-terminal pro-B-type natriuretic peptide.
Poortvliet RK; van Peet PG; de Craen AJ; Mertens BJ; Mooijaart SP; Wijsman LW; Drewes YM; Ford I; Sattar N; Jukema JW; Stott DJ; de Ruijter W; Gussekloo J
Eur J Prev Cardiol; 2016 Jul; 23(10):1104-13. PubMed ID: 26603744
[TBL] [Abstract][Full Text] [Related]
7. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
Olsen MH; Wachtell K; Nielsen OW; Hall C; Wergeland R; Ibsen H; Kjeldsen SE; Devereux RB; Dahlöf B; Hildebrandt PR
J Hypertens; 2006 Aug; 24(8):1531-9. PubMed ID: 16877955
[TBL] [Abstract][Full Text] [Related]
8. High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.
Harutyunyan MJ; Mathiasen AB; Winkel P; Gøtze JP; Hansen JF; Hildebrandt P; Jensen GB; Hilden J; Jespersen CM; Kjøller E; Kolmos HJ; Gluud C; Kastrup J;
Scand J Clin Lab Invest; 2011 Feb; 71(1):52-62. PubMed ID: 21108561
[TBL] [Abstract][Full Text] [Related]
9. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
Skoglund PH; Arpegård J; Ostergren J; Svensson P
Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
[TBL] [Abstract][Full Text] [Related]
11. Amino-Terminal Pro-B-Type Natriuretic Peptide Improves Discrimination for Incident Atherosclerotic Cardiovascular Disease Beyond Ambulatory Blood Pressure in Elderly Men.
Skoglund PH; Höijer J; Ärnlöv J; Zethelius B; Svensson P
Hypertension; 2015 Sep; 66(3):681-6; discussion 445. PubMed ID: 26150437
[TBL] [Abstract][Full Text] [Related]
12. Socioeconomic position is associated with N-terminal pro-brain natriuretic peptide (NT-proBNP)-Results of the population-based Heinz Nixdorf Recall study.
Rudman M; Frank M; Emmel C; Matusch E; Kara K; Mahabadi AA; Erbel R; Jöckel KH; Dragano N; Schmidt B
PLoS One; 2021; 16(8):e0255786. PubMed ID: 34415953
[TBL] [Abstract][Full Text] [Related]
13. Nighttime home blood pressure as a mediator of N-terminal pro-brain natriuretic peptide in cardiovascular events.
Hoshide S; Kanegae H; Kario K
Hypertens Res; 2021 Sep; 44(9):1138-1146. PubMed ID: 34244693
[TBL] [Abstract][Full Text] [Related]
14. Impact of N-terminal pro-B-type natriuretic peptide and related inflammatory biomarkers on periodontal treatment outcomes in patients with periodontitis: An explorative human randomized-controlled clinical trial.
Isola G; Tartaglia GM; Santonocito S; Polizzi A; Williams RC; Iorio-Siciliano V
J Periodontol; 2023 Dec; 94(12):1414-1424. PubMed ID: 37433155
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P
Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589
[TBL] [Abstract][Full Text] [Related]
16. Amino-terminal pro-B-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population: the Rotterdam study.
Rutten JH; Mattace-Raso FU; Steyerberg EW; Lindemans J; Hofman A; Wieberdink RG; Breteler MM; Witteman JC; van den Meiracker AH
Hypertension; 2010 Mar; 55(3):785-91. PubMed ID: 20083731
[TBL] [Abstract][Full Text] [Related]
17. N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients.
Duprez DA; Neuhaus J; Tracy R; Kuller LH; Deeks SG; Orkin C; Stoehr A; Woolley IJ; Neaton JD;
AIDS; 2011 Mar; 25(5):651-7. PubMed ID: 21245726
[TBL] [Abstract][Full Text] [Related]
18. N-terminal probrain natriuretic peptide is a stronger predictor of cardiovascular mortality than C-reactive protein and albumin excretion rate in elderly patients with type 2 diabetes: the Casale Monferrato population-based study.
Bruno G; Landi A; Barutta F; Ghezzo G; Baldin C; Spadafora L; Schimmenti A; Prinzis T; Cavallo Perin P; Gruden G
Diabetes Care; 2013 Sep; 36(9):2677-82. PubMed ID: 23564918
[TBL] [Abstract][Full Text] [Related]
19. N-terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population-based study.
Wannamethee SG; Welsh P; Whincup PH; Lennon L; Papacosta O; Sattar N
Eur J Heart Fail; 2014 Jan; 16(1):25-32. PubMed ID: 23901058
[TBL] [Abstract][Full Text] [Related]
20. N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.
Price AH; Welsh P; Weir CJ; Feinkohl I; Robertson CM; Morling JR; McLachlan S; Strachan MW; Sattar N; Price JF
Diabetologia; 2014 Dec; 57(12):2505-12. PubMed ID: 25231020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
